Stockreport

Kyverna Therapeutics Announces Proposed Public Offering of Common Stock

Kyverna Therapeutics, Inc.  (KYTX) 
PDF EMERYVILLE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on deve [Read more]